Skip to main content
Equibles

Ameritas Investment Partners, Inc.

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1055980 LINCOLN, NE
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,377
+$3,023 QoQ
Shares Held
708
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 95 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. RNAC ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 12,422 $6,170,379
2 EXEL
Exelixis, Inc.
 75,969 $4,133,473
3 HALO
Halozyme Therapeutics, Inc.
 40,729 $3,187,858
4 CYTK
Cytokinetics Inc
 36,992 $3,151,348
5 ROIV
Roivant Sciences Ltd.
 83,064 $2,939,634
6 REGN
Regeneron Pharmaceuticals, Inc.
 4,593 $2,863,919
7 JAZZ
Jazz Pharmaceuticals plc
 11,547 $2,782,480
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 25,923 $2,112,983

All Filings in RNAC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,377 708
2026-03-31 $4,354 708
2025-12-31 $5,104 708
2025-09-30 $7,235 708
2025-06-30 $7,356 708
2025-03-31 $9,331 708
2024-12-31 $12,680 708
2024-09-30 $11,412 708
2024-06-30 $19,123 708
2024-03-31 $6,234 9,591
2023-12-31 $6,608 9,591
2023-09-30 $10,166 9,591
2023-06-30 $10,741 9,591
2022-03-31 $7,368 5,991
2021-12-31 $19,530 5,991
2021-09-30 $24,922 5,991
2021-06-30 $25,042 5,991
2021-03-31 $27,109 5,991
2020-12-31 $18,152 5,991
2020-09-30 $14,857 5,991
2020-06-30 $17,014 5,991